$37.96
-0.14-0.37%
Last update: Oct 30, 8:30 AM
Definium Therapeutics Inc
DFTXNASDAQ
Definium Therapeutics (DFTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.56 | $-0.49 | $-0.47 | $-0.51 |
| Actual | $-1.44 | $-0.71 | $-0.50 | $-0.78 |
| Surprise | -157.1% | -44.9% | -6.38% | -52.9% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.56 | $-0.53 | $-0.50 | $-0.51 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-1.44 | $-0.56 | -157.1 % |
| Q1 | May 7, 2026 | $-0.71 | $-0.49 | -44.9 % |
| Q4 | Feb 26, 2026 | $-0.50 | $-0.47 | -6.38 % |
| Q3 | Nov 6, 2025 | $-0.78 | $-0.51 | -52.9 % |
